Drug
Aln Cideb
Aln Cideb: highest development phase Phase 3, developed by Regeneron. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Regeneron
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALN-CIDEB NCT07854782 | Phase 3 | Metabolic Dysfunction-Associated Steatotic Liver Disease |
| ALN-CIDEB NCT07631637 | Phase 2 | Metabolic Dysfunction-Associated Steatohepatitis |
Latest
No recent events.
Follow Aln Cideb on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.